206 related articles for article (PubMed ID: 38802732)
21. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
[TBL] [Abstract][Full Text] [Related]
22. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure.
Yen FL; Wu TH; Lin LT; Cham TM; Lin CC
Pharm Res; 2009 Apr; 26(4):893-902. PubMed ID: 19034626
[TBL] [Abstract][Full Text] [Related]
23. Augmented anticancer activity of naringenin-loaded TPGS polymeric nanosuspension for drug resistive MCF-7 human breast cancer cells.
Rajamani S; Radhakrishnan A; Sengodan T; Thangavelu S
Drug Dev Ind Pharm; 2018 Nov; 44(11):1752-1761. PubMed ID: 29968480
[TBL] [Abstract][Full Text] [Related]
24. The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus.
Cataneo AHD; Kuczera D; Koishi AC; Zanluca C; Silveira GF; Arruda TB; Suzukawa AA; Bortot LO; Dias-Baruffi M; Verri WA; Robert AW; Stimamiglio MA; Duarte Dos Santos CN; Wowk PF; Bordignon J
Sci Rep; 2019 Nov; 9(1):16348. PubMed ID: 31705028
[TBL] [Abstract][Full Text] [Related]
25. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962
[TBL] [Abstract][Full Text] [Related]
26. The cardioprotective effects and mechanisms of naringenin in myocardial ischemia based on network pharmacology and experiment verification.
Yang Y; Qi J; Zhang M; Chen P; Liu Y; Sun X; Chu L
Front Pharmacol; 2022; 13():954555. PubMed ID: 36160433
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the Mitochondrial BK
Kicinska A; Kampa RP; Daniluk J; Sek A; Jarmuszkiewicz W; Szewczyk A; Bednarczyk P
Molecules; 2020 Jun; 25(13):. PubMed ID: 32630135
[TBL] [Abstract][Full Text] [Related]
28. The Citrus Flavanone Naringenin Produces Cardioprotective Effects in Hearts from 1 Year Old Rat, through Activation of mitoBK Channels.
Testai L; Da Pozzo E; Piano I; Pistelli L; Gargini C; Breschi MC; Braca A; Martini C; Martelli A; Calderone V
Front Pharmacol; 2017; 8():71. PubMed ID: 28289383
[No Abstract] [Full Text] [Related]
29. Synergism Potentiates Oxidative Antiproliferative Effects of Naringenin and Quercetin in MCF-7 Breast Cancer Cells.
Rhman MA; Devnarain N; Khan R; Owira PMO
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014942
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic Comparisons of Naringenin and Naringenin-Nicotinamide Cocrystal in Rats by LC-MS/MS.
Xu D; Zhang GQ; Zhang TT; Jin B; Ma C
J Anal Methods Chem; 2020; 2020():8364218. PubMed ID: 32322425
[TBL] [Abstract][Full Text] [Related]
31. Naringenin Nano-Delivery Systems and Their Therapeutic Applications.
Bhia M; Motallebi M; Abadi B; Zarepour A; Pereira-Silva M; Saremnejad F; Santos AC; Zarrabi A; Melero A; Jafari SM; Shakibaei M
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33672366
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of naringenin on estrogen deficiency-induced obesity via regulation of mitochondrial dynamics and AMPK activation associated with white adipose tissue browning.
Pan T; Lee YM; Takimoto E; Ueda K; Liu PY; Shen HH
Life Sci; 2024 Mar; 340():122453. PubMed ID: 38272439
[TBL] [Abstract][Full Text] [Related]
33. The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1.
Testai L; Piragine E; Piano I; Flori L; Da Pozzo E; Miragliotta V; Pirone A; Citi V; Di Cesare Mannelli L; Brogi S; Carpi S; Martelli A; Nieri P; Martini C; Ghelardini C; Gargini C; Calderone V
Oxid Med Cell Longev; 2020; 2020():4650207. PubMed ID: 32047577
[TBL] [Abstract][Full Text] [Related]
34. Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity.
Torcasio R; Gallo Cantafio ME; Veneziano C; De Marco C; Ganino L; Valentino I; Occhiuzzi MA; Perrotta ID; Mancuso T; Conforti F; Rizzuti B; Martino EA; Gentile M; Neri A; Viglietto G; Grande F; Amodio N
J Transl Med; 2024 Feb; 22(1):208. PubMed ID: 38413989
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of optimized naringenin nanoformulations using nano-carriers (PLA/PVA and zein/pectin) for improvement of bioavailability.
Smruthi MR; Nallamuthu I; Anand T
Food Chem; 2022 Feb; 369():130950. PubMed ID: 34474288
[TBL] [Abstract][Full Text] [Related]
36. Rationally Designed Naringenin-Conjugated Polyester Nanoparticles Enable Folate Receptor-Mediated Peroral Delivery of Insulin.
Heyns IM; Ganugula R; Varma T; Allamreddy S; Kumar N; Garg P; Kumar MNVR; Arora M
ACS Appl Mater Interfaces; 2023 Oct; 15(39):45651-45657. PubMed ID: 37728532
[TBL] [Abstract][Full Text] [Related]
37. Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells.
Liu X; Zhao T; Shi Z; Hu C; Li Q; Sun C
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446609
[TBL] [Abstract][Full Text] [Related]
38. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
39. Anticancer Potential of Naringenin, Biosynthesis, Molecular Target, and Structural Perspectives.
Prakash O; Singh R; Singh N; Usmani S; Arif M; Kumar R; Ved A
Mini Rev Med Chem; 2022; 22(5):758-769. PubMed ID: 34517796
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of novel composite nanoparticles using zein and hyaluronic acid for efficient delivery of naringenin.
Ye G; Wu T; Li Z; Teng M; Ma L; Qin M; Zhao P; Fu Q
Food Chem; 2023 Aug; 417():135890. PubMed ID: 36933431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
